Detalhe da pesquisa
1.
Cases of pleural effusion possibly due to clinical pleuroperitoneal communication in the perioperative period of emergency gynecologic surgery: Case series and literature review.
J Obstet Gynaecol Res
; 50(4): 734-739, 2024 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-38196307
2.
Formulation design and evaluation of liposomal sepantronium bromide (YM155), a small-molecule survivin suppressant, based on pharmacokinetic modeling and simulation.
Pharm Res
; 32(1): 238-47, 2015 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-25033765
3.
Sepantronium bromide (YM155) enhances response of human B-cell non-Hodgkin lymphoma to rituximab.
J Pharmacol Exp Ther
; 343(1): 178-83, 2012 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-22787117
4.
Days of Antibiotic Spectrum Coverage Trends and Assessment in Patients with Bloodstream Infections: A Japanese University Hospital Pilot Study.
Antibiotics (Basel)
; 11(12)2022 Dec 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-36551402
5.
A mixed Müllerian cystadenoma presenting as a paraurethral tumor.
Gynecol Oncol Rep
; 35: 100684, 2021 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-33364289
6.
Laparoscopic Hysterectomy for Benign Pathology Does Not Yield More Perioperative Complications than Abdominal or Vaginal Hysterectomies: Our Experience in Introducing Laparoscopic Hysterectomy.
Gynecol Minim Invasive Ther
; 9(4): 215-219, 2020.
Artigo
em Inglês
| MEDLINE | ID: mdl-33312865
7.
Effects of serotonin 5-HT(3) receptor antagonists on CRF-induced abnormal colonic water transport and defecation in rats.
Eur J Pharmacol
; 587(1-3): 281-4, 2008 Jun 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-18456254
8.
Antitumor efficacy and biodistribution of liposomal sepantronium bromide (YM155), a novel small-molecule survivin suppressant.
Eur J Pharm Biopharm
; 88(1): 283-9, 2014 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-24993306
9.
Antitumor effects of YM155, a novel survivin suppressant, against human aggressive non-Hodgkin lymphoma.
Leuk Res
; 35(6): 787-92, 2011 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-21237508
10.
YM155, a selective survivin suppressant, inhibits tumor spread and prolongs survival in a spontaneous metastatic model of human triple negative breast cancer.
Int J Oncol
; 39(3): 569-75, 2011 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-21674125